Literature DB >> 3113597

Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centres: a retrospective review.

M M Gray, I M Hann, S Glass, O B Eden, P M Jones, R F Stevens.   

Abstract

Measles is a major cause of mortality and morbidity in children receiving treatment for leukaemia. A review was made of all the documented cases of measles in children in first remission from acute lymphoblastic leukaemia at four major treatment centres in 1974-84. Over the 11 years reviewed 1043 children with acute lymphoblastic leukaemia were referred to these centres. Fifty one (4.9%) died while in first remission and 15 (29.4%) of these deaths were due to measles or its complications: 12 cases of pneumonia, 10 of them fatal; and six cases of encephalitis, five of them fatal and the sixth child left severely handicapped. These children would have had at least a 50% chance of long term survival. The severity of measles in the immunocompromised patient reinforces the need to improve the poor uptake of measles immunisation in Britain.

Entities:  

Mesh:

Year:  1987        PMID: 3113597      PMCID: PMC1246900          DOI: 10.1136/bmj.295.6589.19

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Audit Reports-Measles immunisation.

Authors:  P Anderson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

2.  Prevention of measles: vaccine efficacy and potential effectiveness of a vaccination programme on entry to school.

Authors:  V Fernandes; O N Gill
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-14

3.  Immunoglobulin prophylaxis of measles in acute lymphoblastic leukaemia.

Authors:  H E Kay; A Rankin
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

4.  Reasons for admission to hospital and complications in children with measles.

Authors:  E Walker; F Gardner
Journal:  Health Bull (Edinb)       Date:  1983-11

5.  Childhood immunoprophylaxis: achievements in a Glasgow practice.

Authors:  S K Ross
Journal:  Health Bull (Edinb)       Date:  1983-09

6.  Measles immunisation: why have we failed?

Authors:  A G Campbell
Journal:  Arch Dis Child       Date:  1983-01       Impact factor: 3.791

7.  Progress in measles elimination.

Authors:  A R Hinman; D L Eddins; C D Kirby; W A Orenstein; R H Bernier; P M Turner; A B Bloch
Journal:  JAMA       Date:  1982-03-19       Impact factor: 56.272

8.  Application of live attenuated measles and mumps vaccines in children with acute leukemia.

Authors:  S Torigoe; S Hirai; K Oitani; M Ito; T Ihara; T Iwasa; H Kamiya; M Sakurai; S Ueda; K Yamanishi
Journal:  Biken J       Date:  1981-12

9.  Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.

Authors:  I M Hann; H G Prentice; H A Blacklock; M G Ross; D Brigden; A E Rosling; C Burke; D H Crawford; W Brumfitt; A V Hoffbrand
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

10.  Possible interferon response in a child with measles encephalitis during immunosuppression.

Authors:  R Simpson; O B Eden
Journal:  Scand J Infect Dis       Date:  1984
View more
  7 in total

1.  Measles in children who have malignant disease.

Authors:  J Kernahan; J McQuillin; A W Craft
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04

Review 2.  Immunisation for the immunosuppressed child.

Authors:  A G Campbell
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

3.  CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

Authors:  M G von Herrath; M Yokoyama; J Dockter; M B Oldstone; J L Whitton
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 4.  Practical review of immunizations in adult patients with cancer.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Hum Vaccin Immunother       Date:  2015-06-25       Impact factor: 3.452

5.  Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia.

Authors:  I Hughes; M E Jenney; R W Newton; D J Morris; P E Klapper
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

Review 6.  Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-07-17

7.  Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer.

Authors:  Sara R Marquis; Jennifer K Logue; Helen Y Chu; Tillie Loeffelholz; Z Z Quinn; Catherine Liu; F Marc Stewart; Paul A Carpenter; Steven A Pergam; Elizabeth M Krantz
Journal:  JAMA Netw Open       Date:  2021-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.